Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Apie Therapeutics Inc.

Headquarters: Cary, NC, United States of America
Year Founded: 2020
Status: Private

BioCentury | Mar 21, 2023
Management Tracks

Debra Yu joins Panacea as partner, COO

Plus: Sonata hires Kite veteran Marincola as CSO and updates from Ascidian, Olink, Azafaros, Akoya and more
BioCentury | Aug 5, 2022
Discovery & Translation

Daley lab’s iPSC-derived T cell differentiation method; plus Harbour’s CTLA-4 antibody and more

BioCentury’s roundup of translational news
BioCentury | Jan 15, 2022
Management Tracks

Founder El-Hibri to retire from Emergent

Plus CEO Sandanayaka shifts to CSO at Nirogy, and updates from Angelini, Apie, 
BioCentury | Mar 25, 2021
Management Tracks

Galapagos promotes Filius to president, Litchfield named Merck CFO; plus moves at LianBio, Adverum, Fulcrum, Aptose, Cyclerion, Medigene, Apie and more

Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) promoted Bart Filius to president from CFO while remaining COO. CEO Onno van de Stolpe will be responsible for oversight of R&D activities. Caroline
Items per page:
1 - 4 of 4